Comment to "effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782 [2]

Annals of Surgical Oncology

Volumn 14, Issue 4, 2007, Pages 1519-1520

  Demicheli, Romano ^a   Hrushesky, William J M ^b   Retsky, Michael W ^c   Bonadonna, Gianni ^a   Valagussa, Pinuccia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b WJB Dorn VA Medical Center   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Breast cancer; Metastasis; Stage IV disease; Surgery; Tumor dormancy

Indexed keywords

FLUOROURACIL;

AUTOCRINE EFFECT; BREAST CANCER; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; HAZARD ASSESSMENT; HUMAN; KAPLAN MEIER METHOD; LETTER; MICROMETASTASIS; RETROSPECTIVE STUDY; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT;

BONE NEOPLASMS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 34047196241     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9279-2     Document Type: Letter

References (10)

1. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor. Ann Surg Oncol 2006; 13:776-82.
2. Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G. Proposal for a new model of breast cancer metastatic development. Ann Oncol 1997; 8:1075-80.
3. Retsky MW, Demicheli R, Swartzendruber DE, et al. Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 1997; 45:193-202.
4. Holmgren L, O-Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1:149-53.
5. Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002; 62:2162-8.
6. Guba M, Cernaianu G, Koehl G, et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res 2001; 61:5575-9.
7. O-Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-28.
8. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1982; 39:3861-5.
9. Demicheli R, Miceli R, Moliterni A, et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol 2005; 16:1449-57.
10. Bissell MJ, Labarge MA. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005; 7:17-23.